Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Interest Coverage Ratio (2016 - 2017)

CytomX Therapeutics (CTMX) has disclosed Interest Coverage Ratio for 4 consecutive years, with 41.82 as the latest value for Q1 2017.

  • For the quarter ending Q1 2017, Interest Coverage Ratio rose 8.78% year-over-year to 41.82, compared with a TTM value of 224.56 through Dec 2017, down 536.52%, and an annual FY2016 reading of 35.28, down 84.03% over the prior year.
  • Interest Coverage Ratio was 41.82 for Q1 2017 at CytomX Therapeutics, down from 36.58 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 13.58 in Q2 2015 and bottomed at 45.84 in Q1 2016.
  • Average Interest Coverage Ratio over 4 years is 30.97, with a median of 30.8 recorded in 2016.
  • The sharpest move saw Interest Coverage Ratio grew 28.3% in 2015, then plummeted 125.74% in 2016.
  • Year by year, Interest Coverage Ratio stood at 42.74 in 2014, then grew by 28.3% to 30.65 in 2015, then dropped by 19.35% to 36.58 in 2016, then decreased by 14.31% to 41.82 in 2017.
  • Business Quant data shows Interest Coverage Ratio for CTMX at 41.82 in Q1 2017, 36.58 in Q4 2016, and 30.95 in Q3 2016.